Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy

Hepatology

Volumn 46, Issue 5, 2007, Pages 1365-1374

  Binder, Marco ^a   Kochs, Georg ^b   Bartenschlager, Ralf ^a   Lohmann, Volker ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; INTERFERON BETA PROMOTER STIMULATOR 1; INTERFERON REGULATORY FACTOR 3; MITOCHONDRIAL PROTEIN; UNCLASSIFIED DRUG; VIRUS RNA; BETA INTERFERON; HEPACIVIRIN; PLASMID DNA; RETINOIC ACID INDUCIBLE PROTEIN I;

ARTICLE; CONTROLLED STUDY; GENE; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; INNATE IMMUNITY; PRIORITY JOURNAL; RETINOIC ACID INDUCIBLE 1 GENE; SIGNAL TRANSDUCTION; VIRUS REPLICATION; HEPATOCELLULAR CARCINOMA CELL LINE; HOST CELL; HUH 7 CANCER CELL LINE; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; PROMOTER REGION; PROTEIN EXPRESSION; RNA REPLICATION; VECTOR CONTROL;

CELL LINE; DEAD-BOX RNA HELICASES; HEPACIVIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON REGULATORY FACTOR-3; RNA, DOUBLE-STRANDED; RNA, VIRAL; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 36348936640     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21829     Document Type: Article

References (27)

1. Thimme R, Lohmann V, Weber F. A target on the move: innate and adaptive immune escape strategies of hepatitis C virus. Antiviral Res 2006;69:129-141.
2. Van Boxel-Dezaire AH, Rani M, Stark G. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 2006;25:361-372.
3. Hoofnagle J, Mullen K, Jones D, Rustgi V, Di Bisceglie A, Peters M, et al. Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon: a preliminary report. N Engl J Med 1986;315:1575-1578.
4. Grandvaux N, Servant M, Tenoever B, Sen G, Balachandran S, Barber G, et al. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J Virol 2002;76:5532-5539.
5. Foy E, Li K, Wang C, Sumpter RJ, Ikeda M, Lemon S, et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 2003;300:1145-1148.
6. Li K, Foy E, Ferreon J, Nakamura M, Ferreon A, Ikeda M, et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 2005;102:2992-2997.
7. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005;437:1167-1172.
8. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005;23:19-28.
9. Bartenschlager R. Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture. Curr Opin Microbiol 2006;9:416-422.
10. Li K, Chen Z, Kato N, Gale MJ, Lemon S. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem 2005;280:16739-16747.
11. Sumpter RJ, Loo Y, Foy E, Li K, Yoneyama M, Fujita T, et al. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 2005;79:2689-2699.
12. Blight KJ, Mckeating J, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 2002;76:13001-13014.
13. Quinkert D, Bartenschlager R, Lohmann V. Quantitative analysis of the hepatitis C virus replication complex. J Virol 2005;79:13594-13605.
14. Koutsoudakis G, Kaul A, Steinmann E, Kallis S, Lohmann V, Pietschmann T, et al. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J Virol 2006;80:5308-5320.
15. Windisch M, Frese M, Kaul A, Trippler M, Lohmann V, Bartenschlager R. Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line. J Virol 2005;79:13778-13793.
16. Binder M, Quinkert D, Bochkarova O, Klein R, Kezmic N, Bartenschlager R, et al. Identification of determinants involved in initiation of hepatitis C virus RNA synthesis by using intergenotypic replicase chimeras. J Virol 2007;81:5270-5283.
17. Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S, Steinmann E, et al. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci U S A 2006;103:7408-7413.
18. Lohmann V, Hoffmann S, Herian U, Penin F, Bartenschlager R. Viral and cellular determinants of hepatitis C virus RNA replication in cell culture. J Virol 2003;77:3007-3019.
19. Saito T, Hirai R, Loo Y, Owen D, Johnson C, Sinha S, et al. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A 2006;104:582-587.
20. Lin R, Lacoste J, Nakhaei P, Sun Q, Yang L, Paz S, et al. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J Virol 2006;80:6072-6083.
21. Loo Y, Owen D, Li K, Erickson A, Johnson C, Fish PM, et al. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A 2006;103:6001-6006.
22. Vilasco M, Larrea E, Vitour D, Dabo S, Breiman A, Regnault B, et al. The protein kinase IKKepsilon can inhibit HCV expression independently of IFN and its own expression is downregulated in HCV-infected livers. HEPATOLOGY 2006;44:1635-1647.
23. Aly H, Watashi K, Hijikata M, Kaneko H, Takada Y, Egawa H, et al. Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes. J Hepatol 2007;46:26-36.
24. Johnson C, Owen DM, Gale MJ. Functional and therapeuric analysis of hepatitis C virus NS3/4A protease control of antiviral immune defense. J Biol Chem 2007;282:10792-10803.
25. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004;5:730-737.
26. Pichlmair A, Schulz O, Tan C, Naslund T, Liljestrom P, Weber F, et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 2006;314:997-1001.
27. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, Kato H, et al. 5′-Triphosphate RNA is the ligand for RIG-I. Science 2006;314:994-997.